Real-World Treatment Patterns and Switching Following Moderate/Severe Chronic Obstructive Pulmonary Disease Exacerbation in Patients with Commercial or Medicare Insurance in the Un... by Bogart M, Germain G, Laliberté F, Lejeune D, Duh MS

Get full text

Characterizing Real-World Use Of Tiotropium In Asthma In The USA by Averell CM, Laliberté F, Duh MS, Wu JW, Germain G, Faison S

Get full text

Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population by Bogart M, Stanford RH, Laliberté F, Germain G, Wu JW, Duh MS

Get full text

Real-World Study of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol on Asthma Control in the US by Bogart M, Germain G, Laliberté F, Mahendran M, Duh MS, DiRocco K, Noorduyn SG, Paczkowski R, Balkissoon R

Get full text

Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Co... by Kalhan R, Slade D, Ray R, Moretz C, Germain G, Laliberté F, Shen Q, Duh MS, MacKnight SD, Hahn B

Get full text

CDP840: a novel inhibitor of PDE-4. by Perry, M, O'Connell, J, Walker, C, Crabbe, T, Baldock, D, Russell, A, Lumb, S, Huang, Z, Howat, D, Allen, R, Merriman, M, Walls, J, Daniel, T, Hughes, B, Laliberte, F, Higgs, G, Owens, R